NFKB1 and T-cell non-Hodgkin lymphoma: Studies based on high-throughput sequencing in the past decade have revealed that oncogenic genetic aberrations in components of the T cell activation/NF-κB pathway are hallmarks of T cell lymphomas (30, 31).